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ABSTRACT
Objective: Anxiety is one of the most common and serious mental illness affecting humankind and its extensiveness is on the rise at an 
alarming rate. Anxiolytic substances are highly acclaimed in the ranking of the most utilized drugs by human. The clinical applications of 
most widely used anxiolytic agents, that is, benzodiazepines are restricted by their undesirable side effects. Therefore, the development of 
new pharmacological agents for the treatment of this problem is well justified. Among medicinal plants, Melilotus officinalis (yellow sweet 
clover) has been recommended for relief of insomnia, convulsions, and as nervine tonic in traditional system of medicine. Nevertheless, no 
pharmacological studies have thus far evaluated its anxiolytic effect. Therefore, the aim of this study was to evaluate antianxiety effect of 
different extracts of M. officinalis in mice.
Methods: The extracts of roots and aerial parts of the plant were prepared according to the polarity, that is, petroleum ether, chloroform, ethanol, 
and water. The anxiolytic effects of petroleum ether, chloroform, ethanol, and aqueous extract of aerial parts and roots of the plant (50, 100, and 
200 mg/kg, p.o) were examined in albino mice using elevated plus maze (EPM) and mirror-chamber models of anxiety. High-performance thin layer 
chromatography (HPTLC) studies were carried out using toluene: Acetone: Formic acid as mobile phase.
Results: Various extracts prepared from roots did not produce significant effect in both the models, whereas the ethanol extract prepared from aerial 
parts at 100 and 200 mg/kg showed a significant anxiolytic effect as compared to control and standard group. The petroleum ether, chloroform, and 
water extracts (50, 100, and 200 mg/kg) of the aerial parts of the plant did not produce meaningful effects in this study. HPTLC analysis of the ethanol 
extract revealed the presence of nine components.
Conclusion: These results suggest that the ethanol extract of aerial parts of M. officinalis plant has statistically significant dose-dependent antianxiety 
activity which can be attributed to the presence of coumarin, and flavonoid compounds in it.
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INTRODUCTION
The plant Melilotus officinalis commonly known as yellow sweet clover 
or honey lotus belonging to family Leguminosae (Fabaceae) is a sweet 
smelling annual or biennial herb. This plant has wide spectrum of 
pharmacological activities and all of its parts are used for medicinal 
purposes [1]. The plant is used for the treatment of inflammation, 
edema, foot ulcers, and headache [2]. In addition, M. officinalis has 
been reported to be a hypotensive, antioxidant, antifungal [3-5], and 
analgesic agent [6].
Substantial phytochemical work has been done on this plant which 
shows the presence of coumarin, glycosides, saponins, triterpenoid 
sapogenols [7-10], and phenolic compounds, for example, quercetin, 
kampferol, rutin, and umbelliferone [11].
The plant yellow sweet clover has traditionally been used in the 
treatment of convulsions, insomnia, and as nervine tonic [12,13]. 
Ethnopharmacological reports on M. officinalis suggest that this plant 
was used for the treatment of neuropsychiatric disorders.
Despite a history of use of this plant as medicine for the treatment of 
neuropsychiatric disorders, this plant has not been investigated so far 
to substantiate these therapeutic claims and no experimental study 
is available on antianxiety evaluation of the plant. Therefore, it was 
envisioned to investigate the anxiolytic effect of different extracts of 
roots and aerial parts of M. officinalis in mice using elevated plus maze 
(EPM) and mirror chamber test as animal models.
METHODS
Plant material
The roots and aerial parts of yellow sweet clover M. officinalis were 
procured from Hind herbs store, Village Khurrampur, Saharanpur, 
Uttar Pradesh, and authenticated at the Department of Botanical and 
Environmental Sciences where the herbarium specimen was deposited 
(SR/Bot.Sci./1667) for the future reference.
Preparation of the plant extracts
The dried roots and aerial parts of M. officinalis (2 kg) were reduced to 
moderately coarse powder by passing through sieve no. 22. The powdered 
drug was Soxhlet extracted with petroleum ether, chloroform, and ethanol 
successively [14]. The ultimate dried marc of the plant was macerated 
with distilled water for 24 hrs and filtered. Then, the extractives were 
obtained on evaporation of solvents using rotary vacuum evaporator and 
dried extracts were preserved at 4°C for the future use.
Drugs
Diazepam hydrochloride (2 mg/kg) was used as a standard drug in the 
present study. All chemicals and solvents were of analytical grade.
Animals and treatment regimens
Albino mice weighing 20-25 g of either sex were used. The animals were 
kept in rooms maintained at 25°C with a 12 hrs light/dark cycle and 
were given standard laboratory feed and water. They were familiarized 
with their surroundings for 2 weeks before starting the experiment. 
Groups of six mice (20-25 g) were used in all sets of experiments. The 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i6.17183
Research Article
397
Asian J Pharm Clin Res, Vol 10, Issue 6, 2017, 396-399
 Kaur et al. 
experiments were conducted in a semi-sound proof laboratory. All 
the experiments were conducted according to the guidelines of the 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals, Ministry of Environment and Forests, India, and protocols 
were duly approved by the Institutional Animal Ethics Committee, 
Guru Nanak Dev University, Amritsar. The animals were divided into 
eight groups containing six mice each and given treatment - Group I 
- control (0.5% carboxymethylcellulose), Group II - treated animals 
received diazepam (2 mg/kg), and Group III, IV, and V were treated with 
different root extracts of the plant at a dose of 50,100, and 200 mg/kg, 
respectively. Group VI, VII, and VIII were treated with different extracts 
of the plant prepared from aerial parts at a dose of 50,100, and 
200 mg/kg orally. Initially, a preliminary screening was carried out to 
select the dose for anxiolytic activity and three doses, namely, 50,100, 
and 200 mg/kg of M. officinalis were selected.
EPM model
The maze comprised two open arms of 50×10 cm and two closed arms 
of 50×10×40 cm, extending from a central platform and elevated to 
a height of 50 cm above the floor. The maze was placed inside a light 
and sound-attenuated room. The experimental animals were treated 
with vehicle, diazepam (2 mg/kg) and the extracts were given orally at 
a dose of 50,100, and 200 mg/kg before evaluation in the maze. Dose 
administration schedule was adjusted in such a way that each mouse 
was placed on EPM after 60 minutes of drug treatment. Every measure 
was taken to ensure that mice are not exposed to any external stimuli, 
other than the height of the plus maze which could elicit anxiety in mice. 
Mice were individually placed on the center of the maze facing an open 
arm, and the number of entries and the time spent in closed and open 
arms were recorded during a 5 minutes observation period [15,16].
Mirror chamber test
The mirrored-chamber apparatus comprised a mirrored cube (30 cm 
on a side) open on one side that was placed inside a square wooden box 
(40×40×30.5 cm). The mirrored cube was constructed of five pieces of 
mirrored glass. The mirrors used were mirrored on one surface only 
(back surface being painted dark brown). The three mirrored side panes, 
a top pane, and floor pane faced the interior of the cube. The mirrored 
cube was placed in the center of the wooden container to form a 5 cm 
corridor that completely surrounded the mirror chamber. A mirror 
was also placed on the container wall so that it faced the single open 
side of the mirrored chamber. The other three walls of the container 
were painted dark brown. 60 minutes after the administration of the 
control, test drug, and standard, the mice were placed individually in 
the chamber of mirrors at a fixed corner. During 5 minutes test period, 
the mean time spent and number of entries in the mirror chamber were 
observed [17].
High-performance thin layer chromatography (HPTLC) studies
Pre-coated and pre-activated TLC plates (E. Merck No. 5548) of silica gel 
60 F254 with the support of aluminum sheets having thickness of 0.1 mm 
were used. 2 g of ethanol extract was weighed accurately and dissolved 
in 20 mL of ethanol. Solutions were then refluxed for 30 minutes on 
water bath at 60-70°C. The extracts were cooled, filtered, and finally the 
volume was made up to 20 mL with ethanol. The sample was applied 
on TLC plate in the form of band using an automatic sample application 
device (LINOMAT, CAMAG) with bandwidth of 9 mm. The quantity of 
sample applied was 10 µL. After optimization of mobile phase, a solvent 
system comprised Toluene:Acetone:Formic acid (7:3:0.5) was selected 
to give the best resolution. The detecting reagent was anisaldehyde in 
sulfuric acid followed by heating at 110°C for 5 minutes.
Preliminary phytochemical screening of ethanol extract
The ethanol extract was screened for different classes of 
phytoconstituents, that is, alkaloids, glycosides, coumarins, and 
flavonoids [18].
Statistical analysis
The anxiolytic activities of the extracts, diazepam, and control were 
analyzed by one-way ANOVA. The test groups were compared with 
control and standard by Tukey’s multiple range test. The difference was 
considered statistically significant at p<0.05.
RESULTS
Human anxiety is a feeling of unpredictability, trepidation, or 
emotional strain arising from the anticipation of fictitious or unreal 
threat. Anxiety has become an important research area in the field of 
central nervous system (CNS) disorders as it affects one-eighth of the 
population worldwide [19]. Benzodiazepines (BZDs), barbiturates, and 
antidepressants have been used for long time to treat anxiety disorders. 
The usage of these drugs in patients is limited due to the serious side 
effects, namely, rebound insomnia, drowsiness, withdrawal, sexual 
dysfunction, and impaired motor coordination [20]. In the present 
era, where mental disorders are highly prevalent and recognition of 
dreadful side effects and addiction liabilities associated with long-
term administration of synthetic drugs have evoked the attention of 
researchers toward medicinal plants. Plants such as Withania somnifera, 
Valeriana officinalis, Nardostachys jatamansi, and Passiflora spp. 
have been used extensively in various traditional systems of therapy 
because of their adaptogenic and psychotropic properties. Inclusion 
of these well-established CNS affecting plants in modern therapeutics 
has reinvigorated the belief of researchers in natural products [21]. 
Despite the widespread traditional use of yellow sweet clover for 
treating various disorders, there are no reports of scientific evaluation 
of its anxiolytic activity; therefore, the present study was undertaken 
to explore the anxiolytic potential of the plant. The animal model used 
for evaluation of anxiolytic effect should have high ecological validity, 
should be based on the study of spontaneous behavior patterns and 
EPM test is the ideal model for studying the effect. The expression of 
anxiety by mice is exhibited by decrease in motor activity on EPM which 
is measured by time spent and number of entries in open arms [22].
The ethanol extract prepared from aerial parts of plant at dose levels of 
100 and 200 mg/kg showed significant increase in time spent in open 
arms and mean number of entries in EPM (Fig. 1) and other extracts 
were found to be ineffective. The different extracts of roots of plants did 
not produce meaningful effect on EPM at the various test doses (Fig. 2).
An approach-avoidance conflict is exhibited by many animal species 
on placement of a mirror in their environment. The extended latency 
to enter the chamber of mirrors is used as a parameter of anxiety 
analogy [23]. In the mirror chamber test, the M. officinalis ethanol 
extract (aerial parts) increased the total number of entries and time 
spent by the animals in the mirror chamber at the dose of 200 mg/kg 
Fig. 1: Anxiolytic profile of M. officinalis (aerial parts) extracts. 
(a) Mean number of entries in open arms and (b) mean time 
spent in open arms. Values are expressed as mean±standard 
error mean (n=6) ap<0.05 compared with vehicle-treated control, 
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when compared with the control and standard group (Fig. 3). The root 
extracts were found to be devoid of anxiolytic activity as shown in 
Fig. 4. The roots extracts were unable to exhibit antianxiety activity in 
both the animal models, therefore, they were eliminated from further 
phytochemical investigation. The antianxiety response was partially 
reverted when doses were increased from 200 mg/kg due to sedative 
effects (data not shown), and therefore, no further evaluation was done.
Phytochemical screening
Various phytochemical tests performed on ethanol extract showed 
the presence of tannins, coumarin, flavonoids, amino acids, and 
carbohydrates.
TLC-densitometry studies
TLC-densitometry studies showed the presence of nine components in 
the bioactive ethanol extract as shown in Fig. 5 and Table 1.
DISCUSSION
The results of the present study revealed that the ethanol extract 
possess anxiolytic effect at therapeutically acceptable doses. HPTLC 
studies on ethanol extract showed the presence of nine compounds. 
Preliminary phytochemical screening of ethanol extract exhibited the 
presence of flavonoids, coumarin, amino acids, carbohydrates, and 
tannins which implies that this plant is rich in phenolic components. 
Plants with high flavonoid content have been traditionally used as cure 
for nervous disorders and now they have been identified as a new type 
of ligand with in vivo anxiolytic properties [24]. A report has suggested 
that neuroprotective action of flavonoids is highly enhanced by the 
general bioavailability of flavonoids, and particularly by their presence 
(in vivo) in the brain [25]. Another study revealed that fractions from 
inflorescences of Tilia americana enriched in kampferol exerted 
anxiolytic activities in the EPM in mice [26]. A relatively mild or a high 
affinity for gamma-aminobutyric acid (GABAA)/BZD receptors with a 
partial agonist action have been shown by some flavonoids [27-29].
Another study reported that the coumarin derivatives are potent 
inhibitors of the enzyme monoamine oxidase [30]. It has been 
proposed that there is binding of coumarin derivatives with the BZD 
site of the GABAA receptor [31]. There are investigations indicating 
Fig. 2: Anxiolytic profile of M. officinalis (roots) extracts. (a) Mean 
number of entries in open arms and (b) mean time spent in open 
arms. Values are expressed as mean±standard error mean (n=6) 
ap<0.05 compared with vehicle-treated control, bp<0.05 compared 
with standard; one-way ANOVA followed by studentized 
Tukey’s test
Fig. 3: Anxiolytic profile of M. officinalis (aerial parts) extracts 
in mirror-chamber model. (a) Mean number of entries in 
mirror chamber and (b) mean time spent in mirror chamber. 
Values are expressed as mean±standard error mean (n=6). 
ap<0.05 compared with vehicle-treated control, bp<0.05 
compared with standard; one-way ANOVA followed by 
studentized Tukey’s test
Fig. 4: Anxiolytic profile of M. officinalis (roots) extracts in 
mirror-chamber model. (a) Mean number of entries in mirror 
chamber and (b) mean time spent in mirror chamber. Values 
are expressed as mean±standard error mean (n=6) ap<0.05 
compared with vehicle-treated control, bp<0.05 compared with 
standard; one-way ANOVA followed by studentized Tukey’s test
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that these modulation of monoamine oxidase (MAO) inhibitors 
modulate monoamine levels in the brain (dopamine, serotonin, and 
norepinephrine) and provoke behavioral modifications in rodents, 
thus exerting an anxiolytic effect. All these findings advocate that the 
mechanism underlying the anxiolytic activity of the plant may occur 
through the inhibition of MAO-A, increase in the GABAergic action, and 
increase in serotonin level, respectively, and phenolic compounds act as 
a ligand for receptors exerting anxiolytic and slight sedative effects. The 
anxiolytic effect of ethanol extract of aerial parts of plant could be due 
to the interaction of the phytoconstituents present in plant with these 
neural substrates. Therefore, the antianxiety action of M. officinalis 
could be related at least in part to compounds present in ethanol extract.
CONCLUSION
The present study validates the traditional claim of M. officinalis as 
cure for anxiety as ethanol extract of aerial parts produced a significant 
antianxiety effect. Since there is a need for new safer and cost-effective 
anxiolytic compounds with little side effects in contrast to synthetic 
medication, aerial parts of M. officinalis could be used to develop a safer 
anxiolytic drug. Further, phytochemical investigations are underway to 
isolate the active principles of plant responsible for the reported activity.
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